BIOFRONTERA AG (BFRA) Stock Price, Quote, News and Overview
NASDAQ:BFRA - Nasdaq - ADR
BFRA Quote, Performance and Key Statistics
NASDAQ:BFRA (3/4/2022, 8:19:41 PM)
2.67
-0.28 (-9.49%)
The current stock price of BFRA is 2.67 null. In the past month the price decreased by -6.97%. In the past year, price decreased by -55.35%.
BFRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About BFRA
Company Profile
Biofrontera AG engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 167 full-time employees. The company went IPO on 2006-10-30. The firm develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itching, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The firm is also engaged in clinical development of two drug candidates: BF-derm1, a tablet with inhibitor blocking the synthesis of histamine in cells, a cause of allergic reactions; and BF1, a selective serotonin receptor to prevent migraines. The firm operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MM Familien KG.
Company Info
BIOFRONTERA AG
Hemmelrather Weg 201
Leverkusen NORDRHEIN-WESTFALEN D-51377 DE
CEO: Hermann Lubbert
Employees: 167
Company Website: https://biofrontera.com/
Phone: 49214876320.0
BIOFRONTERA AG / BFRA FAQ
What is the stock price of BIOFRONTERA AG today?
The current stock price of BFRA is 2.67 null. The price decreased by -9.49% in the last trading session.
What is the ticker symbol for BIOFRONTERA AG stock?
The exchange symbol of BIOFRONTERA AG is BFRA and it is listed on the Nasdaq exchange.
On which exchange is BFRA stock listed?
BFRA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for BIOFRONTERA AG stock?
5 analysts have analysed BFRA and the average price target is 14.22 null. This implies a price increase of 432.69% is expected in the next year compared to the current price of 2.67. Check the BIOFRONTERA AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOFRONTERA AG worth?
BIOFRONTERA AG (BFRA) has a market capitalization of 151.44M null. This makes BFRA a Micro Cap stock.
How many employees does BIOFRONTERA AG have?
BIOFRONTERA AG (BFRA) currently has 167 employees.
What are the support and resistance levels for BIOFRONTERA AG (BFRA) stock?
BIOFRONTERA AG (BFRA) has a resistance level at 2.78. Check the full technical report for a detailed analysis of BFRA support and resistance levels.
Is BIOFRONTERA AG (BFRA) expected to grow?
The Revenue of BIOFRONTERA AG (BFRA) is expected to decline by -5.25% in the next year. Check the estimates tab for more information on the BFRA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIOFRONTERA AG (BFRA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BFRA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BFRA, evaluating the profitability, health, valuation and growth aspects
- BIOFRONTERA AG (BFRA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOFRONTERA AG (BFRA) Sales and EPS estimates to see what analysts future expectations are.
- BIOFRONTERA AG (BFRA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOFRONTERA AG (BFRA) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOFRONTERA AG (BFRA) Stock Chart to make your own analysis
- BIOFRONTERA AG (BFRA) Latest news and press-releases to stay up to date.
Does BIOFRONTERA AG (BFRA) stock pay dividends?
BFRA does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIOFRONTERA AG (BFRA)?
BIOFRONTERA AG (BFRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.29).
BFRA Technical Analysis
BFRA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BFRA. There are concerns on the financial health of BFRA while its profitability can be described as average.
BFRA Financial Highlights
Over the last trailing twelve months BFRA reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS increased by 23.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -55.98% | ||
| ROA | -22.64% | ||
| ROE | N/A | ||
| Debt/Equity | 0.13 |
BFRA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to BFRA. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of -137.77% and a revenue growth -5.25% for BFRA